Tuberculosis, HIV, malaria dominate active clinical trials
Nairobi, Sept. 21 -- Research into tuberculosis (TB), HIV and malaria accounts for 50 percent of all active clinical trials in Kenya across four main categories listed by the Pharmacy and Poisons Board (PPB), making it the largest research area in the country.
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
Published by HT Digital Content Services with permission from Business Daily....
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.